-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $310

Benzinga·08/26/2026 10:41:13
Listen to the news
Needham analyst Ami Fadia maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and raises the price target from $292 to $310.